Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 163

1.

The rheumatology of gout.

Sundy JS.

Adv Chronic Kidney Dis. 2012 Nov;19(6):404-12. doi: 10.1053/j.ackd.2012.07.012. Review. Erratum in: Adv Chronic Kidney Dis. 2013 Jan;20(1):110. Dosage error in article text.

PMID:
23089276
2.

Update on gout and hyperuricemia.

Baker JF, Schumacher HR.

Int J Clin Pract. 2010 Feb;64(3):371-7. doi: 10.1111/j.1742-1241.2009.02188.x. Epub 2009 Nov 10. Review.

PMID:
19909378
3.

CaseBook challenges: Managing gout, hyperuricemia and comorbidities -- dialogue with the experts.

Bakris GL, Doghramji PP, Keenan RT, Silber SH.

Am J Med. 2014 Jan;127(1):S1. doi: 10.1016/j.amjmed.2013.11.001. Epub 2013 Nov 19.

PMID:
24268074
4.

Hyperuricemia and gout: a reign of complacency.

Mandell BF.

Cleve Clin J Med. 2002 Aug;69(8):589-90, 592-3. No abstract available.

PMID:
12184467
5.

[Gout: an overview of available urate lowering therapies].

Richette P.

Ann Pharm Fr. 2012 May;70(3):133-8. doi: 10.1016/j.pharma.2012.02.003. Epub 2012 Apr 27. Review. French.

PMID:
22655581
6.

2011 Recommendations for the diagnosis and management of gout and hyperuricemia.

Hamburger M, Baraf HS, Adamson TC 3rd, Basile J, Bass L, Cole B, Doghramji PP, Guadagnoli GA, Hamburger F, Harford R, Lieberman JA 3rd, Mandel DR, Mandelbrot DA, McClain BP, Mizuno E, Morton AH, Mount DB, Pope RS, Rosenthal KG, Setoodeh K, Skosey JL, Edwards NL; European League Against Rheumatism.

Postgrad Med. 2011 Nov;123(6 Suppl 1):3-36. doi: 10.3810/pgm.2011.11.2511.

PMID:
22156509
7.

Safety of urate-lowering therapies: managing the risks to gain the benefits.

Keenan RT.

Rheum Dis Clin North Am. 2012 Nov;38(4):663-80. doi: 10.1016/j.rdc.2012.08.008. Epub 2012 Sep 7. Review.

PMID:
23137576
8.

The current state of care in gout: Addressing the need for better understanding of an ancient disease.

Zychowicz ME, Pope RS, Graser E.

J Am Acad Nurse Pract. 2010 Nov;22 Suppl 1:623-36. doi: 10.1111/j.1745-7599.2010.00556.x. Epub 2010 Nov 3.

PMID:
21054636
9.

[Allopurinol efficacy in patients with tophus gout and chronic renal failure].

Iakunina IA, Barskova VG, Nasonova VA.

Ter Arkh. 2006;78(6):88-91. Russian. No abstract available.

PMID:
16881370
10.

Febuxostat compared with allopurinol in patients with hyperuricemia and gout.

Becker MA, Schumacher HR Jr, Wortmann RL, MacDonald PA, Eustace D, Palo WA, Streit J, Joseph-Ridge N.

N Engl J Med. 2005 Dec 8;353(23):2450-61.

11.

Clinical efficacy and safety of successful longterm urate lowering with febuxostat or allopurinol in subjects with gout.

Becker MA, Schumacher HR, MacDonald PA, Lloyd E, Lademacher C.

J Rheumatol. 2009 Jun;36(6):1273-82. doi: 10.3899/jrheum.080814. Epub 2009 Mar 13.

PMID:
19286847
12.

Gout: a clinical syndrome illustrated and discussed.

Bhansing KJ, van Bon L, Janssen M, Radstake TR.

Neth J Med. 2010 Sep;68(9):352-9. Review.

13.

Metabolic diseases: gout.

Falasca GF.

Clin Dermatol. 2006 Nov-Dec;24(6):498-508. Review.

PMID:
17113968
14.

Febuxostat--treatment for hyperuricemia and gout?

Moreland LW.

N Engl J Med. 2005 Dec 8;353(23):2505-7. No abstract available.

PMID:
16339099
15.

An allopurinol-controlled, randomized, double-dummy, double-blind, parallel between-group, comparative study of febuxostat (TMX-67), a non-purine-selective inhibitor of xanthine oxidase, in patients with hyperuricemia including those with gout in Japan: phase 3 clinical study.

Kamatani N, Fujimori S, Hada T, Hosoya T, Kohri K, Nakamura T, Ueda T, Yamamoto T, Yamanaka H, Matsuzawa Y.

J Clin Rheumatol. 2011 Jun;17(4 Suppl 2):S13-8. doi: 10.1097/RHU.0b013e31821d36cc.

PMID:
21654265
16.

Febuxostat for the treatment of hyperuricaemia in people with gout: a single technology appraisal.

Stevenson M, Pandor A.

Health Technol Assess. 2009 Oct;13 Suppl 3:37-42. doi: 10.3310/hta13suppl3/06. Review.

17.

Gout: what primary care physicians want to know.

Dore RK.

J Clin Rheumatol. 2008 Oct;14(5 Suppl):S47-54. doi: 10.1097/RHU.0b013e3181896c35. Review.

PMID:
18830091
18.

Clinical inquiry. Are serum uric acid levels always elevated in acute gout?

Leiszler M, Poddar S, Fletcher A.

J Fam Pract. 2011 Oct;60(10):618-20. Review.

PMID:
21977490
19.

Febuxostat.

Hair PI, McCormack PL, Keating GM.

Drugs. 2008;68(13):1865-74. Review.

PMID:
18729537
20.

[Gout].

Leclercq P, Malaise MG.

Rev Med Liege. 2004 May;59(5):274-80. Review. French.

Supplemental Content

Support Center